Highland Investment Advisors LLC’s Takeda Pharmaceutical TAK Stock Holding History

Highland Investment Advisors LLC’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22K	Buy	+76	New	+$1.26K	﹤0.01%	535

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

MAP

Managed Asset Portfolios Rochester, Michigan $875M AUM 41.9% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Highland Investment Advisors LLC's TAK Position: Q2 2026 in Review

Highland Investment Advisors LLC opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 76 shares worth $1.22K. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings.

303 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Highland Investment Advisors LLC held 76 shares of Takeda Pharmaceutical worth $1.22K as of Q2 2026.
Takeda Pharmaceutical was a new Highland Investment Advisors LLC position in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Highland Investment Advisors LLC's portfolio in Q2 2026, its #535 holding.
303 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Highland Investment Advisors LLC's 13F filing for Q2 2026, filed 13 Aug 2026.